Skip to main content
Journal ArticleOPEN ACCESS

In Vivo selection of rifamycin-resistant clostridium difficile during rifaximin therapy

Antimicrobial Agents and Chemotherapy (2012) 56(11) 6019-6020
DOI: 10.1128/AAC.00974-12
29Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the selection of Clostridium difficile resistant to the rifamycin class of antibiotics in a patient within 32 h of receiving rifaximin for the treatment of recurrent C. difficile diarrhea. Resistance was associated with single nucleotide substitutions within rpoB. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Carman, R. J., Boone, J. H., Grover, H., Wickham, K. N., & Chen, L. (2012). In Vivo selection of rifamycin-resistant clostridium difficile during rifaximin therapy. Antimicrobial Agents and Chemotherapy, 56(11), 6019–6020. https://doi.org/10.1128/AAC.00974-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free